» Articles » PMID: 25984666

Fine-needle Aspirate CYFRA 21-1, an Innovative New Marker for Diagnosis of Axillary Lymph Node Metastasis in Breast Cancer Patients

Overview
Specialty General Medicine
Date 2015 May 19
PMID 25984666
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

To compare the value of cytokeratin fragment 21-1 (CYFRA 21-1) concentration in the fine-needle biopsy aspirates (fine needle aspirate [FNA] CYFRA 21-1) with cytopathology of fine-needle aspiration biopsy (FNA cytology) and to assess whether CYFRA 21-1 concentrations from ultrasound-guided fine-needle aspiration biopsy (US-FNAB) specimens (FNA CYFRA 21-1) is not inferior to FNA cytology in the diagnosis of axillary lymph node (ALN) metastasis of breast cancer patients.This study received institutional review board approval, and written informed consent was obtained from all patients. US-FNAB was performed in 373 ALNs from 358 patients with invasive breast cancer. Concentrations of CYFRA 21-1 were measured from washouts of the syringe used during US-FNAB (FNA CYFRA 21-1), and ALN metastasis was determined using a cutoff value of 1.93 ng/mL. FNA cytology, intraoperative sentinel lymph node biopsy, and surgical pathology results were reviewed and analyzed. The noninferiority margin for the difference in accuracies between FNA cytology and FNA CYFRA 21-1 was set as 5%.Among 373 ALNs, 136 (36.5%) were benign, and 237 (63.5%) were metastatic. The mean FNA CYFRA 21-1 was significantly higher in metastatic ALNs compared to that in benign ALNs (P = 0.001). For the diagnosis of ALN metastasis, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FNA CYFRA 21-1 (cutoff value 1.93 ng/mL) were not significantly different from those of FNA cytology (P > 0.05). FNA CYFRA 21-1 reached statistical noninferiority to FNA cytology in terms of diagnostic accuracy for ALN metastasis. Of the 20 ALNs (8 metastasis, 12 benign) that showed insufficient results on FNA cytology, FNA CYFRA 21-1 accurately diagnosed 15 ALNs (4 metastasis, 11 benign).The diagnostic performance of FNA CYFRA 21-1 is comparable with that of FNA cytology for breast cancer ALN metastasis. Our results indicate that FNA CYFRA 21-1, using an US-FNAB specimen, can be a useful method equal to FNA cytology in terms of diagnostic accuracy.

Citing Articles

Diagnostic utilities of washout CYFRA 21-1 combined with washout thyroglobulin for metastatic lymph nodes in thyroid cancer: a prospective study.

Park J, An S, Kim K, Kim J, Jung C, Bae J Sci Rep. 2024; 14(1):7599.

PMID: 38556517 PMC: 10982287. DOI: 10.1038/s41598-024-58093-9.


A Comprehensive Analysis of KRT19 Combined with Immune Infiltration to Predict Breast Cancer Prognosis.

Mi L, Liang N, Sun H Genes (Basel). 2022; 13(10).

PMID: 36292723 PMC: 9602083. DOI: 10.3390/genes13101838.


[Diagnostic Value of CYFRA 21-1 Measurement in Fine-Needle Aspiration Washouts for Detection of Axillary Recurrence in Postoperative Breast Cancer Patients].

Won S, Kim E, Moon H, Yoon J, Park V, Kim M Taehan Yongsang Uihakhoe Chi. 2022; 81(1):147-156.

PMID: 36238108 PMC: 9432102. DOI: 10.3348/jksr.2020.81.1.147.


Diagnostic Accuracy of Fine-Needle Aspiration Cytology and Core-Needle Biopsy in the Assessment of the Axillary Lymph Nodes in Breast Cancer-A Meta-Analysis.

Pyo J, Jung J, Lee S, Kim N, Kang D Diagnostics (Basel). 2020; 10(9).

PMID: 32962089 PMC: 7555252. DOI: 10.3390/diagnostics10090717.


Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.

Lin Q, Chen X, Liu W, Zhu P, Shi W, Li B Cancer Med. 2019; 9(4):1279-1286.

PMID: 31218849 PMC: 7013068. DOI: 10.1002/cam4.2354.

References
1.
Molina R, Agusti C, Filella X, Jo J, Joseph J, Gimenez N . Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases. Tumour Biol. 1994; 15(6):318-25. DOI: 10.1159/000217908. View

2.
Choi J, Kim M, Moon H, Kim E, Yoon J . False negative results of preoperative axillary ultrasound in patients with invasive breast cancer: correlations with clinicopathologic findings. Ultrasound Med Biol. 2012; 38(11):1881-6. DOI: 10.1016/j.ultrasmedbio.2012.07.011. View

3.
Pathmanathan N, Jones W, Salisbury E, Bilous M . Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: initial experience and lessons learnt in establishing a new practice. Pathology. 2006; 38(4):321-7. DOI: 10.1080/00313020600820922. View

4.
Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, Rees C . Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. DOI: 10.1038/35021093. View

5.
Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F . One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007; 13(16):4807-16. DOI: 10.1158/1078-0432.CCR-06-2512. View